Clinical and economic impact of mirabegron compared with antimuscarinics for the treatment of overactive bladder in Canada-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical and economic impact of mirabegron compared with antimuscarinics for the treatment of overactive bladder in Canada

Published:2017-03-12 Issue:6 Volume:20 Page:614-622
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Hakimi Zalmai¹,Nazir Jameel²,McCrea Charles³,Berling Malin⁴,Fatoye Francis⁵,Ramos Barbara⁶,Wagg Adrian⁷

Affiliation:

1. Astellas Pharma Europe B.V., Leiden, the Netherlands;

2. Astellas Pharma Europe Ltd., Chertsey, UK;

3. PAREXEL Access Consulting, London, UK;

4. PAREXEL Access Consulting, Stockholm, Sweden;

5. Manchester Metropolitan University, Manchester, UK;

6. Astellas Pharma Canada, Markham, Ontario, Canada;

7. University of Alberta, Edmonton, Canada

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2017.1294595

Reference51 articles.

1. Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder

2. Prevalence and burden of overactive bladder in the United States

3. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study

4. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frailty, Specialized Care, and Sociodemographic Factors: Disparities in Oral Pharmacotherapy Class Utilization Among Medicare Part D Beneficiaries With Overactive Bladder in the United States;Urology;2024-09

2. Cost-Utility Analysis of Mirabegron Compared to Solifenacin in the Treatment of Overactive Bladder (OAB) in Iran;Iranian Journal of Pharmaceutical Research;2023-11-08

3. Developmental strategy for swellable/erodible matrix tablet of mirabegron: quality by design approach with various geometric properties and pharmacokinetic evaluation;Journal of Pharmaceutical Investigation;2023-11

4. Inequities in Filled Overactive Bladder Medication Prescriptions in the US;JAMA Network Open;2023-05-24

5. Uso de recursos y costes sanitarios en pacientes con vejiga hiperactiva que inician tratamiento con mirabegrón o un antimuscarínico en monoterapia en Cataluña: estudio MIRACAT;Actas Urológicas Españolas;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3